TABLE 3.
Grading system of evidence and recommendation.
| Guideline | Grading System Used | Description of Evidence | Description of Recommendation |
|---|---|---|---|
| Qiu, HB 2021 (Association SoCRDoCM, 2021) | GRADE | High; Moderate; Low; Very low | Strong; Weak |
| Collins, T. 2020 (Collins et al., 2020) | GRADE | High (1); Moderate (2); Low (3); Very low (4) | Strong; Moderate; Weak |
| Chou, C.C. 2018 (Chou et al., 2018) | GRADE | High [A]; Moderate [B]; Low [C]; Very low [D] | Strong [1]; Weak [2] |
| Qu, JM 2018 (Infectious disease group RmboCMA, 2018) | Self-defined | High(I); Moderate (II); Low (III) | Strong(A); Moderate(B); Weak(C) |
| Lenoe, M. 2018 (Leone et al., 2018) | GRADE | Strong; Moderate; Weak; Very weak | GRADE 1+; GRADE 1-; GRADE 2+; GRADE 2- |
| Torres, A. 2017 (Torres et al., 2017) | GRADE | High; Moderate; Low; Very low | Strong; Weak |
| Mikasa, K. 2016 (Mikasa et al., 2016) | Self-defined | I (Randomized comparative study); II (Non-randomized comparative study); III (Case report); IV (Specialist’s opinion) | A (strongly recommended); B (general recommendation), C (comprehensive evaluation by the attending physician) |
| Kalil, A.C. 2016 (Kalil et al., 2016) | GRADE | High; Moderate; Low; Very low | Strong; Weak |
| Mehta, Y. 2014 (Mehta et al., 2014) | GRADE | High (A) to very low (C) | Strong (grade 1); weak (grade 2) |
| Klompas, M. 2014 (Klompas et al., 2014) | GRADE and Canadian Task Force on Preventive Health Care | High(I); Moderate (II); Low (III) | Basic practices; Special approaches; Generally not Recommended; No recommendation |
| Alvarez-Lerma, F. 2014 (Álvarez Lerma et al., 2014) | GRADE | High; Moderate; Low; Very low | Strong; Weak |
| Li, YM 2013 (Association CcmboCM, 2013) | GRADE | High(A); moderate(B); low(C); very low(D) | Strong (1); Weak (2) |
| Gupta, D. 2012 (Gupta et al., 2012) | Modified GRADE system | Level 1; Level 2; Level 3; Useful practice point | GRADE A; GRADE B |
GRADE: Grading of Recommendations Assessment, Development and Evaluation.